Connection between genetic variation and immune system, risk for neurodegenerative and other disease

Researchers from Brigham and Women's Hospital (BWH), Harvard Medical School (HMS), the Broad Institute of MIT and Harvard, Massachusetts General Hospital (MGH), and University of Chicago report findings demonstrating how genetic variations among healthy, young individuals can influence immune cell function. Many of those variants are also genetic risk factors for common diseases such as Alzheimer's disease, diabetes, and multiple sclerosis later in life, offering new insight into disease pathology.

The study will be published in the May 2, 2014 issue of Science.

"Over the last decade, geneticists have identified hundreds of for several human diseases, but the functional consequences of those factors on relevant cells are largely unknown," said Towfique Raj, PhD, BWH Department of Neurology and a postdoctoral scholar at the Broad Institute, lead study author. "Our study highlights the potential role of in human diseases."

The study was conducted as part of the ImmVar Project, which leveraged BWH's PhenoGenetic Project, a "living biobank" of healthy volunteers willing to contribute blood samples to understand how human genetic variations affect how the human body functions.

The researchers recruited a subset of 461 volunteers from the PhenoGenetic Project of African American, East Asian American, or European American ancestry. Two different types of immune cells—T cells and monocytes—were purified from each individual's blood, representing the adaptive and innate arms of immunity, respectively. The researchers profiled these cells to measure the expression of 19,114 genes in each cell type. They then examined genetic variants throughout the human genome for their effects on gene expression in these two representative populations of immune cells.

They discovered that genetic variation influencing a person's risk for multiple sclerosis, rheumatoid arthritis, and type 1diabetes is more likely to control gene activity in T cells than in monocytes. In contrast, genetic variation that increases one's risk for neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, shows a striking enrichment of functional effects in monocytes.

"This study shows that our genomes introduce changes in the immune system early on," said Christophe Benoist, MD, PhD, HMS, Broad Institute associate member, and study author. "These changes influence how a person responds to additional risk factors that he or she may encounter over the course of their life, making them more or less susceptible to triggering a disease process such as type 1, or juvenile, diabetes."

"The study focuses our attention on a particular part of the immune system that already exhibits changes caused by Alzheimer in people in their 20s and 30s," said Philip L. De Jager, MD, PhD, director, BWH Program in Translational NeuroPsychiatric Genomics, associate member at the Broad Institute, senior study author. "Functionally, we cannot say that blood-derived are the key cell type for Alzheimer's disease. They are likely to be proxies for the infiltrating and resident cells found at the sites of neuropathology. However, these exciting insights encourage us to explore how manipulating these immune cell types may one day slow or contribute to stopping the accumulation of Alzheimer's disease pathology that occurs as each of us ages."

By including volunteers of different genetic ancestries, the researchers also found that genetic variation that alters immune function is highly shared across human populations of different ancestry.

"Our multi-ethnic exploration of innate and adaptive immunity highlights a remarkable level of sharing across human populations of genetic variation influencing immune function, while identifying interesting instances of genetic effects on that are specific to a population," said Nir Hacohen, PhD, MGH and the Broad Institute, study author.

"This study extends the narrative that many of the effects of disease-related genetic variation are specific to a certain context, such as a given immune cell type," said Barbara Stranger, PhD, University of Chicago, senior study author. "Thus, it is clear that further studies must investigate an increasingly complex matrix of cell types and conditions to fully understand the role of human in disease."

More information: "Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes" Science, 2014.

add to favorites email to friend print save as pdf

Related Stories

Taking immune cells for a test drive

Mar 17, 2014

You're on a crowded subway car and someone nearby sneezes. Influenza viruses shed by your fellow rider are expelled in droplets of saliva that land on you and the person next to you. Two days later, you begin suffering from ...

Research team implants human innate immune cells in mice

Mar 18, 2014

(Phys.org) —Overcoming a major limitation to the study of the origins and progress of human disease, Yale researchers report that they have transplanted human innate immune cells into mouse models, which ...

Did evolution give us inflammatory disease?

Mar 21, 2013

In new research published on March 21, 2013 in the online issue of The American Journal of Human Genetics, researchers from Brigham and Women's Hospital (BWH) demonstrate that some variants in our genes that contribute to a p ...

Recommended for you

Researchers find new mechanism for neurodegeneration

Jul 24, 2014

A research team led by Jackson Laboratory Professor and Howard Hughes Investigator Susan Ackerman, Ph.D., have pinpointed a surprising mechanism behind neurodegeneration in mice, one that involves a defect in a key component ...

Schizophrenia's genetic architecture revealed (w/ Video)

Jul 23, 2014

Queensland scientists are closer to effective treatments for schizophrenia after uncovering dozens of sites across the human genome that are strongly associated with a genetic predisposition to schizophrenia.

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

JVK
1 / 5 (1) May 02, 2014
The olfactory system(s) and the immune system of mammals have the same embryonic origin, which explains why nutrient stress and social stress epigenetically effect embryonic development of the gondadotropin releasing hormone neuronal system, and how food odors and social odors (called pheromones) link the epigenetic landscape to the physical landscape of our DNA via one-carbon metabolism and DNA methylation thoughout life.

See for review: Nutrient-dependent/pheromone-controlled adaptive evolution: a model
http://www.socioa...53/27989

See also: Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism and DNA methylation http://www.scienc...12000599